Latest filing published 19 Feb 2025 for Keros Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Yung H. Chyung: trading record in brief
Filings by Yung H. Chyung span 3 companies, the busiest being Scholar Rock Holding Corp, Keros Therapeutics, Inc. and Talaris Therapeutics, Inc. We count 5 filings; the first trade dates from 1 February 2021 and the latest from 18 February 2025.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 19 February 2025 came the latest disclosure, a share grant in Keros Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Yung H. Chyung
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 44,000 shares0Common StockSEC:0001415889-25-004598:0
- 56,836 sharesCommon StockSEC:0001209191-23-053391:0
- 37,500 shares0Common StockSEC:0001104659-22-023861:0
- 1,421 shares@ US$19.463100.0% of flowCommon StockSEC:0001104659-22-005566:0
4 of 4 declarations
